Kenneth C.H. Fearon - Concepedia

Author

Kenneth C.H. Fearon

Also Known As

K C Fearon, K C H Fearon, K Fearon, K. C. Fearon, K. C. H. Fearon, K. Fearon, K.C. Fearon, K.C.H. Fearon, KC Fearon, KENNETH C. H. FEARON

183

Publications

16.4K

Citations

H-Index

127

Concepts

All Affiliations

Edinburgh Royal Infirmary University of Edinburgh Scottish Universities Environmental Research Centre Glasgow Royal Infirmary Western General Hospital

About

Kenneth C.H. Fearon is an author at Edinburgh Royal Infirmary specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	47	7.3K
2	Health Sciences	12	12	1.1K
3	Engineering	1	1	50
4	Humanities	1	1	40
5	Natural Sciences	1	1	39

Kenneth C.H. Fearon

Publications

11.7K

Citations

H-Index

Page 1

	Year	Citations
Sarcopenia With Limited Mobility: An International Consensus John E. Morley, Angela Marie Abbatecola, Josep M. Argilés, Journal of the American Medical Directors Association Global HealthInternational ConsensusInternational HealthDisease OutbreakAnatomy	2011	1.1K
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology Jann Arends, G. Bodoky, Federico Bozzetti, Clinical Nutrition NutritionMedicineGastroenterologySurgeryUpper Gastrointestinal Surgery	2006	927
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis Kenneth C.H. Fearon, Anne Coble Voss, Deborah S. Hustead American Journal of Clinical Nutrition ObesityNutritionWeight LossCancer CachexiaMedicine	2006	770
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials Jennifer S. Temel, Amy P. Abernethy, David C. Currow, The Lancet Oncology Romana 2Romana 1Non-small-cell Lung CancerMedicinePathology	2016	607
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial Kenneth C.H. Fearon Gut	2003	601
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection Martin Schindl, D N Redhead, Kenneth C.H. Fearon, Gut	2005	544
Characterization of a cancer cachectic factor Penio Todorov, Peter Cariuk, Trudi McDevitt, Nature Tumor BiologyMalignant DiseaseMedicineCancer Cachectic FactorCancer Biology	1996	437
The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer Stephen J. Wigmore, James A. Ross, J. Falconer, Nutrition Metabolic SyndromePancreatic CancerOmega-3 Fatty AcidMedicinePharmacology	1996	296
Double-Blind, Placebo-Controlled, Randomized Study of Eicosapentaenoic Acid Diester in Patients With Cancer Cachexia Kenneth C.H. Fearon, Matthew Barber, Alastair G.W. Moses, Journal of Clinical Oncology	2006	282
Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer Sherif Awad, Benjamin Tan, Helen Cui, Clinical Nutrition Surgical OncologyBody CompositionEsophageal CancerGastrointestinal OncologyMedicine	2011	269

Page 1